Harvard Apparatus Regenerative Technology, Inc. is clinical stage regenerative medicine company developing life-saving medical devices. The Company�s products include Hollow Organ Bioreactors, Solid Organ Bioreactors, Scaffolds, and Clinical Infusion Pump. The Company�s first products are a bioreactor and a synthetic scaffold that can be used by surgeons to create a replacement trachea, or airway, for patients who need an airway transplant. Its bioreactor technology has been used in six human airway transplant surgeries. Its r products are in development. The Company�s products address the critical challenges to trachea transplant, the shortage of suitable donor tracheas. The Company is a wholly owned subsidiary Harvard Bioscience Inc. In October 2013, Harvard Bioscience Inc announced the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc.